Literature DB >> 26175950

Six1 promotes glioblastoma cell proliferation and invasion by upregulation of connective tissue growth factor.

Tian Tian1, Aimin Li2, Hong Lu1, Ran Luo3, Mingzhi Zhang2, Zhaoming Li4.   

Abstract

Glioblastoma multiforme (GBM) is the deadliest and most common form of malignant primary brain tumor in humans. However, until now, little is known about the glioma genesis and progression at the molecular level. Here we report that overexpression of sine oculis homeobox homolog 1 (Six1), a developmental transcription factor implicated in tumor onset and progression, can significantly promote glioblastoma cell proliferation and invasion by upregulating connective tissue growth factor (CTGF). Our results revealed that expression of Six1 mRNA was increased and small hairpin RNAi silencing of Six1 could dramatically inhibit cell proliferation and invasion in GBM. Moreover, it was found that CTGF gene could be transcriptionally regulated by Six1. Its overexpression induced CTGF up-regulation in GBM at both the mRNA and protein level, and significantly enhanced the activity of CTGF promoter in these tumor cells, while decreasing CTGF expression impeded Six1-induced cell proliferation and invasion, revealing that CTGF is required for Six1-mediated GBM growth and metastasis. Collectively, these findings suggest that Six1 overexpression may contribute to cell proliferation and invasion via upregulation of CTGF in GBM. Our study provides new insights into the important roles of Six1 and CTGF in tumor regulation, suggesting that Six1 might be a potential therapeutic target for preventing proliferation and metastasis of GBM.

Entities:  

Keywords:  CTGF; Six1; cell proliferation; glioblastoma; invasion

Year:  2015        PMID: 26175950      PMCID: PMC4497448     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  28 in total

Review 1.  The CCN family proteins in carcinogenesis.

Authors:  A Dhar; A Ray
Journal:  Exp Oncol       Date:  2010-03

2.  Identification of an evolutionarily conserved, functional noncoding element regulated by Six1 homeoprotein.

Authors:  Yongsu Jeong; Sangtaek Oh
Journal:  Genes Genet Syst       Date:  2010       Impact factor: 1.517

3.  Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.

Authors:  Kian Behbakht; Lubna Qamar; Carrie S Aldridge; Ricardo D Coletta; Susan A Davidson; Andrew Thorburn; Heide L Ford
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

4.  Effects of connective tissue growth factor (CTGF) gene silencing on the radiosensitivity of glioblastoma.

Authors:  Na Han; Allahverdi Shahveranov; Yi Cheng; Kai Qin; Shi-Ying Yu; Meng-Xian Zhang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 5.  New strategies in glioblastoma: exploiting the new biology.

Authors:  Howard A Fine
Journal:  Clin Cancer Res       Date:  2015-02-10       Impact factor: 12.531

6.  Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme.

Authors:  Dong Yin; Weikai Chen; James O'Kelly; Daning Lu; Michelle Ham; Ngan B Doan; Dong Xie; Charles Wang; Jay Vadgama; Jonathan W Said; Keith L Black; H Phillip Koeffler
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

7.  Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma.

Authors:  Jamie L Fox; Michael Dews; Andy J Minn; Andrei Thomas-Tikhonenko
Journal:  RNA       Date:  2012-12-18       Impact factor: 4.942

8.  Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development.

Authors:  Oleg V Lagutin; Changqi C Zhu; Daisuke Kobayashi; Jacek Topczewski; Kenji Shimamura; Luis Puelles; Helen R C Russell; Peter J McKinnon; Lilianna Solnica-Krezel; Guillermo Oliver
Journal:  Genes Dev       Date:  2003-02-01       Impact factor: 11.361

9.  Transcriptional differences between normal and glioma-derived glial progenitor cells identify a core set of dysregulated genes.

Authors:  Romane M Auvergne; Fraser J Sim; Su Wang; Devin Chandler-Militello; Jaclyn Burch; Yazan Al Fanek; Danielle Davis; Abdellatif Benraiss; Kevin Walter; Pragathi Achanta; Mahlon Johnson; Alfredo Quinones-Hinojosa; Sridaran Natesan; Heide L Ford; Steven A Goldman
Journal:  Cell Rep       Date:  2013-05-30       Impact factor: 9.423

10.  Connective tissue growth factor (CTGF/CCN2) is negatively regulated during neuron-glioblastoma interaction.

Authors:  Luciana F Romão; Fabio A Mendes; Natalia M Feitosa; Jane Cristina O Faria; Juliana M Coelho-Aguiar; Jorge Marcondes de Souza; Vivaldo Moura Neto; José Garcia Abreu
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more
  9 in total

1.  Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.

Authors:  Ming-Ru Chiang; Chi-Wen Kuo; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo; Meng-Yao Lu; Yen-Chein Lai
Journal:  Pathol Oncol Res       Date:  2019-01-23       Impact factor: 3.201

2.  Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811.

Authors:  Shi Hui Li; Wen Chuan Dong; Li Fan; Guang Sheng Wang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

3.  SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.

Authors:  Qi Cheng; Deng Ning; Jin Chen; Xue Li; Xiao-Ping Chen; Li Jiang
Journal:  Cancer Biol Ther       Date:  2018-02-12       Impact factor: 4.742

4.  Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.

Authors:  Hanna Drzewiecka; Bartłomiej Gałęcki; Donata Jarmołowska-Jurczyszyn; Andrzej Kluk; Wojciech Dyszkiewicz; Paweł P Jagodziński
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-08       Impact factor: 4.553

5.  MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma.

Authors:  Tian Tian; Ma Mingyi; Xia Qiu; Yang Qiu
Journal:  Oncotarget       Date:  2016-11-29

6.  EYA2 promotes lung cancer cell proliferation by downregulating the expression of PTEN.

Authors:  Zhaoming Li; Ran Qiu; Xia Qiu; Tian Tian
Journal:  Oncotarget       Date:  2017-12-02

7.  Eya2 overexpression promotes the invasion of human astrocytoma through the regulation of ERK/MMP9 signaling.

Authors:  Zhifeng Wen; Chuansheng Liang; Qichen Pan; Yunjie Wang
Journal:  Int J Mol Med       Date:  2017-09-13       Impact factor: 4.101

Review 8.  Signaling pathways and mesenchymal transition in pediatric high-grade glioma.

Authors:  Michaël H Meel; Sophie A Schaper; Gertjan J L Kaspers; Esther Hulleman
Journal:  Cell Mol Life Sci       Date:  2017-11-21       Impact factor: 9.261

9.  SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway.

Authors:  Shanshan Huang; Wanling Lin; Lei Wang; Yuan Gao; Xun Yuan; Peng Zhang; Yuan Chen; Qian Chu
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.